Echo Therapeutics, Inc. Additional Paid in Capital
Echo Therapeutics, Inc. had Additional Paid in Capital of $148.41 million as of 2016-09-30, per its 10-Q filed 2016-11-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2016-11-16
- 2016-09-30: Additional Paid in Capital $148.41M.
- 2016-06-30: Additional Paid in Capital $148.12M.
- 2016-03-31: Additional Paid in Capital $147.79M.
- 2015-12-31: Additional Paid in Capital $147.41M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2016-09-30 | $148.41M 10-Q · filed 2016-11-16 | |
| 2016-06-30 | $148.12M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $147.79M 10-Q · filed 2016-05-20 | |
| 2015-12-31 | $147.41M 10-Q · filed 2016-11-16 | |
| 2015-09-30 | $147.10M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $145.26M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $142.31M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $137.29M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $135.60M 10-Q · filed 2015-04-20 | |
| 2014-06-30 | $135.13M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $133.04M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $132.19M 10-Q · filed 2015-04-20 | |
| 2013-09-30 | $126.96M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $126.82M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $114.58M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $104.06M 10-K · filed 2014-03-28 | $103.66M 10-K · filed 2013-03-18 |
| 2012-09-30 | $99.91M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $99.28M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $98.63M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $98.12M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $88.73M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $87.66M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $79.65M 10-K · filed 2012-03-15 |